Robert F. Pass

19.9k total citations · 5 hit papers
170 papers, 14.1k citations indexed

About

Robert F. Pass is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert F. Pass has authored 170 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Epidemiology, 45 papers in Infectious Diseases and 39 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert F. Pass's work include Cytomegalovirus and herpesvirus research (144 papers), Herpesvirus Infections and Treatments (48 papers) and Parvovirus B19 Infection Studies (39 papers). Robert F. Pass is often cited by papers focused on Cytomegalovirus and herpesvirus research (144 papers), Herpesvirus Infections and Treatments (48 papers) and Parvovirus B19 Infection Studies (39 papers). Robert F. Pass collaborates with scholars based in United States, United Kingdom and Canada. Robert F. Pass's co-authors include Sergio Stagno, Charles A. Alford, Karen B. Fowler, William J. Britt, Suresh B. Boppana, Meyer Dworsky, David W. Reynolds, Arthur J. Dahle, Thomas J. Boll and Michael J. Cannon and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Robert F. Pass

165 papers receiving 13.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status

1992 787 citations Karen B. Fowler, Sergio Stagno et al. profile →
Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994

2006 725 citations Stephanie A. S. Staras, Sheila C. Dollard et al. Clinical Infectious Diseases profile →
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

2003 615 citations Gail J. Demmler, Wayne M. Dankner et al. The Journal of Pediatrics profile →
Congenital Cytomegalovirus Infection

1982 534 citations Sergio Stagno, Robert F. Pass et al. profile →
Vaccine Prevention of Maternal Cytomegalovirus Infection

2009 527 citations Robert F. Pass, Gretchen A. Cloud et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert F. Pass United States	63	12.6k	6.1k	3.0k	1.5k	1.4k	170	14.1k
Sergio Stagno United States	55	10.2k 0.8×	5.2k 0.8×	2.6k 0.9×	1.5k 1.0×	1.3k 0.9×	144	12.2k
Suresh B. Boppana United States	47	9.1k 0.7×	4.8k 0.8×	2.4k 0.8×	1.0k 0.7×	762 0.5×	123	10.1k
Charles A. Alford United States	55	9.6k 0.8×	4.1k 0.7×	1.7k 0.6×	1.1k 0.7×	1.3k 0.9×	123	11.4k
Karen B. Fowler United States	42	7.7k 0.6×	4.2k 0.7×	2.0k 0.7×	761 0.5×	592 0.4×	98	8.7k
Tiziana Lazzarotto Italy	43	5.6k 0.4×	3.3k 0.5×	1.3k 0.4×	534 0.4×	561 0.4×	255	7.2k
Gail J. Demmler United States	44	5.1k 0.4×	2.7k 0.4×	1.2k 0.4×	454 0.3×	343 0.2×	112	6.5k
David W. Kimberlin United States	41	5.8k 0.5×	2.6k 0.4×	903 0.3×	486 0.3×	638 0.4×	153	7.1k
Mark R. Schleiss United States	42	4.8k 0.4×	2.0k 0.3×	814 0.3×	620 0.4×	642 0.4×	209	6.1k
Pablo J. Sánchez United States	53	5.5k 0.4×	2.4k 0.4×	2.7k 0.9×	237 0.2×	496 0.3×	233	10.2k
Sheila C. Dollard United States	35	4.5k 0.4×	2.3k 0.4×	724 0.2×	359 0.2×	592 0.4×	87	5.6k

Countries citing papers authored by Robert F. Pass

Since Specialization

Citations

This map shows the geographic impact of Robert F. Pass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Pass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Pass more than expected).

Fields of papers citing papers by Robert F. Pass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Pass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Pass. The network helps show where Robert F. Pass may publish in the future.

Co-authorship network of co-authors of Robert F. Pass

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Pass. A scholar is included among the top collaborators of Robert F. Pass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Pass. Robert F. Pass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pass, Robert F., et al.. (2022). Antibiotic Use and Outcomes in Young Children Hospitalized With Uncomplicated Community-Acquired Pneumonia. Open Forum Infectious Diseases. 9(4). ofac123–ofac123. 1 indexed citations

Jenks, Jennifer A., Cody S. Nelson, Robert F. Pass, et al.. (2020). Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans. Science Translational Medicine. 12(568). 32 indexed citations

Leruez‐Ville, Marianne, Ina Foulon, Robert F. Pass, & Y. Ville. (2020). Cytomegalovirus infection during pregnancy: state of the science. American Journal of Obstetrics and Gynecology. 223(3). 330–349. 141 indexed citations

Nelson, Cody S., Jennifer A. Jenks, Guanhua Xie, et al.. (2018). HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions. Proceedings of the National Academy of Sciences. 115(24). 6267–6272. 121 indexed citations

Nelson, Cody S., Guanhua Xie, Nathan Vandergrift, et al.. (2018). Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees. Journal of Virology. 93(5). 25 indexed citations

Forman, Michael, Dhananjay Vaidya, Oluwaseyi Bolorunduro, et al.. (2017). Cytomegalovirus Kinetics Following Primary Infection in Healthy Women. The Journal of Infectious Diseases. 215(10). 1523–1526. 18 indexed citations

Cannon, Michael J., et al.. (2012). Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Preventive Medicine. 54(5). 351–357. 81 indexed citations

Flynn, Patricia M., Sharon Nachman, Petronella Muresan, et al.. (2012). Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1-Infected Children, Adolescents, and Young Adults. The Journal of Infectious Diseases. 206(3). 421–430. 20 indexed citations

Hayward, Gary S., Sarah J. Wheelan, Michael Forman, et al.. (2011). Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women. PLoS ONE. 6(1). e15949–e15949. 23 indexed citations

10.

Pass, Robert F.. (2007). Cytomegalovirus (CMV) Envelope Glycoprotein B (gB) Vaccine in Young Women. 1 indexed citations

11.

Staras, Stephanie A. S., Sheila C. Dollard, Kay Radford, et al.. (2006). Seroprevalence of Cytomegalovirus Infection in the United States, 1988-1994. Clinical Infectious Diseases. 43(9). 1143–1151. 725 indexed citations breakdown →

12.

Fowler, Karen B., Arthur J. Dahle, Suresh B. Boppana, & Robert F. Pass. (1999). Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?. The Journal of Pediatrics. 135(1). 60–64. 269 indexed citations

13.

Whitley, R. J., Gretchen A. Cloud, William C. Gruber, et al.. (1997). Ganciclovir Treatment of Symptomatic Congenital Cytomegalovirus Infection: Results of a Phase II Study. The Journal of Infectious Diseases. 175(5). 1080–1086. 219 indexed citations

14.

Zhou, Xiaojian, William C. Gruber, Gail J. Demmler, et al.. (1996). Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections.. Clinical Pharmacology & Therapeutics. 59(2). 184–184. 9 indexed citations

15.

Boppana, Suresh B., et al.. (1994). Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. The Pediatric Infectious Disease Journal. 13(12). 1139–1142. 45 indexed citations

16.

Gruber, William C., Gregory A. Storch, Gail J. Demmler, et al.. (1993). Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clinical Pharmacology & Therapeutics. 53(1). 15–21. 70 indexed citations

17.

Royal, Stuart A., et al.. (1993). Diabetes insipidus associated with symptomatic congenital cytomegalovirus infection. The Journal of Pediatrics. 122(6). 911–913. 21 indexed citations

18.

Fowler, Karen B., et al.. (1993). Congenital cytomegalovirus infection and neonatal auditory screening. The Journal of Pediatrics. 123(5). 779–782. 102 indexed citations

19.

Oh, M. Kim, et al.. (1989). Chlamydia trachomatis cervical infection and oral contraceptive use among adolescent girls. Journal of Adolescent Health Care. 10(5). 376–381. 22 indexed citations

20.

Rubin, Robert H., Nina Tolkoff-Rubin, Donald Oliver, et al.. (1985). MULTICENTER SEROEPIDEMIOLOGIC STUDY OF THE IMPACT OF CYTOMEGALOVIRUS INFECTION ON RENAL TRANSPLANTATION. Transplantation. 40(3). 243–248. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact